B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug combo offers hope for Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing a combination of a targeted cancer drug (inotuzumab ozogamicin), low-intensity chemotherapy, and an immunotherapy drug (blinatumomab) for adults with acute lymphoblastic leukemia (ALL). It focuses on older patients (60+) or younger patients who are too frail…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug combo aims to wipe out leukemia in adults
Disease control Recruiting nowThis study is testing a combination of chemotherapy drugs and a newer enzyme-blocking drug (JZP458) to treat adults newly diagnosed with a fast-growing blood cancer called acute lymphoblastic leukemia (ALL). The goal is to see if this combination can eliminate cancer cells more e…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for tough blood cancers in adults
Disease control Recruiting nowThis study is testing a new drug combination for adults with high-risk, newly diagnosed acute lymphoblastic leukemia or lymphoblastic lymphoma. It aims to see if adding a specific enzyme drug (asparaginase Erwinia chrysanthemi) to standard chemotherapy is safe and effective at co…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for tough leukemia: adding a targeted drug to standard chemotherapy
Disease control Recruiting nowThis study is testing if adding a targeted drug called tafasitamab to a standard chemotherapy regimen works better for treating adults with a specific type of acute lymphoblastic leukemia (B-ALL). The trial aims to see if this combination can more effectively kill cancer cells an…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New Two-Pronged attack tested for Tough-to-Treat adult leukemia
Disease control Recruiting nowThis study is testing a two-step treatment for a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). It is for older adults newly diagnosed or adults whose cancer has returned or not responded to prior treatment. The approach uses two targeted drugs, inotuzumab…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC